| abstract |
The present invention relates to individual, well-defined compounds and the uses of these compounds, alone or in conjunction with bioactive molecules such as growth factors or metalloproteinase inhibitors, for the repair of cartilage damage as, for example, is found in osteoarthritis. Such well-defined compounds may include, but are not limited to, purified components of the extracellular matrix, derivatives of extracellular matrix components, and glycosaminoglycan mimics. |